Full Protocol Guide

GHRP-6 Acetate 10mg

A research-use ghrelin-receptor peptide entry for endocrine-axis context and safety review.

GHRP-6 Acetate 10mg product vial
GHRP-6 Acetate 10mg vial Performance, Recovery & Muscle
ProductGHRP-6 Acetate 10mg
CategoryPerformance, Recovery & Muscle
FormatGHRP-6 Acetate 10mg vial
ReviewSource-linked guide

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

  • Do not start, stop, combine, or change a protocol based only on website content.
  • Emergency symptoms require urgent medical care, not a website or routine follow-up message.

Quickstart Highlights

GHRP-6 is a synthetic growth-hormone-releasing peptide and ghrelin (GHS-R1a) receptor agonist that triggers a short pulse of growth hormone from the pituitary; a hallmark of GHRP-6 is strong hunger and appetite stimulation[1][5]. This educational page outlines a subcutaneous approach on an empty stomach, with a dilution chosen so doses land on easy-to-read insulin-syringe marks. It is an unapproved research chemical, not a medicine, and muscle, recovery and anti-aging benefits are not established by rigorous human trials — presented for research and educational use only.

  • Add 3.0 mL bacteriostatic water to one 10 mg vial → ~3.33 mg/mL (3,333 mcg/mL), the largest practical dilution for accurate dosing.
  • 100–300 mcg per dose, 1–3× daily on an empty stomach, titrated upward gradually across a 12-week course.
  • At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg; 100 mcg ≈ 3 units and 300 mcg ≈ 9 units on a U-100 syringe.
  • Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.
  • Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
Phase / Week(s) Dose & Frequency Volume (U-100 units / mL)
Weeks 1–2 100 mcg (1–3× daily) ~3 units (0.03 mL)
Weeks 3–4 200 mcg (1–3× daily) ~6 units (0.06 mL)
Weeks 5–12 300 mcg (1–3× daily) ~9 units (0.09 mL)
  • Reconstitute: Add 3.0 mL bacteriostatic water to one 10 mg vial → final concentration ~3.33 mg/mL (3,333 mcg/mL).
  • Typical dose: 100–300 mcg per dose, 1–3× daily on an empty stomach, raised gradually over a 12-week course.
  • Easy measuring: At ~3.33 mg/mL, 1 unit ≈ 33.3 mcg on a U-100 syringe, so 100 mcg ≈ 3 units and 300 mcg ≈ 9 units — small, readable volumes on the U-100 scale.
  • Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
  • Frequency: typically 1–3 subcutaneous injections per day on an empty stomach, titrating up as tolerated. The GH response is generally reported to plateau around ~100 mcg per dose, so the protocol is built around that response ceiling rather than ever-larger single doses[3][4]. These figures come from reference protocols, not from approved human dosing.

Reconstitution Steps

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

  • Release it slowly down the vial’s inner wall to limit foaming.
  • Swirl or roll gently until fully dissolved — don’t shake.
  • Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.
  • The 3.0 mL dilution gives ~3.33 mg/mL so each dose reads in clear, low single- and double-digit unit marks on a U-100 syringe. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.
  • Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Quantities below assume an 8–16 week course of once-daily injections with gradual titration.

  • At these microgram doses a 10 mg vial lasts well beyond a week, so only a few vials cover a full course.
  • Low end (~100–200 mcg/day): ~2–3 vials
  • Mid (~300–600 mcg/day): ~4–6 vials
  • High (up to 900 mcg/day): ~8–10 vials
  • Per injection: 1 syringe
  • 12 weeks (1× daily): ~84 syringes
  • 12 weeks (3× daily): ~252 syringes
  • Use ~3.0 mL per 10 mg vial for reconstitution.
  • Low course (~3 vials): ~9 mL → 1 bottle
  • High course (~10 vials): ~30 mL → 3 bottles
  • One for the vial stopper + one for each injection site, every dose.
  • Per injection: 2 swabs
  • 12 weeks (1–3× daily): ~170–500 swabs → 2–5 boxes

Protocol Overview

A concise summary of the once-daily regimen, drawn from commonly cited reference protocols.

  • ▪Goal: Stimulate a short pulse of pituitary growth hormone via the ghrelin (GHS-R1a) receptor; appetite stimulation is the most consistent reported effect — broader benefits are not established in humans[5][6].
  • ▪Schedule: Subcutaneous injections 1–3× daily on an empty stomach for about 12 weeks.
  • ▪Dose Range: 100–300 mcg per dose with gradual titration, built around the ~100 mcg GH-response ceiling.
  • ▪Reconstitution: 3.0 mL bacteriostatic water per 10 mg vial gives ~3.33 mg/mL for accurate unit measurements.
  • ▪Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses.

  • ▪Start: Begin at 100 mcg per dose, 1–3× daily on an empty stomach, to gauge tolerability and appetite response.
  • ▪Titrate: Increase by roughly 100 mcg per dose every two weeks as tolerated.
  • ▪Target: Reach about 300 mcg per dose by weeks 5–12, staying near the ~100 mcg per-dose GH-response ceiling.
  • ▪Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
  • ▪Timing: Inject at a consistent time each day and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

  • ▪Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
  • ▪Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days; do not freeze the mixed solution, as freezing can denature peptides[8].
  • ▪Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
  • ▪Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.

Important Notes

Practical points that keep daily administration safe and consistent.

  • ▪Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
  • ▪Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
  • ▪Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
  • ▪Recordkeeping: Log the daily dose, injection site and any observations to keep the protocol consistent.
  • ▪Regulatory note: GHRP-6 is prohibited by WADA for athletic use and is not FDA-approved for human administration[10].

How This Works

GHRP-6 is a synthetic growth-hormone-releasing peptide — a hexapeptide that acts as an agonist at the ghrelin / GHS-R1a receptor[1][2]. Binding that receptor on the pituitary and hypothalamus drives a pulse of growth-hormone release.

  • Its core mechanism is GH secretagogue activity: it stimulates GH-releasing pathways while suppressing somatostatin, producing a transient rise in growth hormone. A defining feature of GHRP-6 is strong stimulation of hunger and appetite, an effect that follows directly from ghrelin-receptor activation[5][6].
  • Studies also report a modest rise in cortisol and prolactin alongside the GH pulse[11]. Crucially, the GH response tends to plateau near ~100 mcg per dose, so larger single doses add little extra GH while increasing side effects[12].
  • Important caveat: there are no completed human efficacy trials showing that GHRP-6 builds muscle, improves recovery or slows aging. Most data come from short pharmacology and animal studies of GH release. Muscle, recovery and anti-aging claims rest on the GH-pulse mechanism and anecdote, and should be read as hypotheses.
  • GHRP-6 is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.

Lifestyle Factors

Habits that may support healthy growth-hormone output alongside the protocol.

  • ▪Nutrition: GHRP-6 increases appetite, so plan balanced, adequate-protein meals rather than overeating on impulse.
  • ▪Activity & rest: Pair regular activity with real rest; avoid timing doses around large meals, since food blunts the GH response.
  • ▪Sleep: Aim for 7–9 hours, when the largest natural growth-hormone pulses occur.
  • ▪Stress: Manage stress with evidence-based practices, since cortisol can counteract growth-hormone signalling.

Potential Benefits & Side Effects

What short pharmacology and animal studies describe; human evidence is limited and individual results vary.

  • ▪GH release (pharmacology): Reliably triggers a short pulse of growth hormone via the ghrelin/GHS-R1a receptor in human and animal studies[5][6].
  • ▪Appetite stimulation: Strong, consistent increase in hunger — the most reliably reported effect of GHRP-6[11].
  • ▪Short-term tolerability: Generally tolerated in short studies, with mild injection-site reactions reported.
  • ▪Note on humans: Muscle, recovery and anti-aging benefits are not established in humans — no large-scale clinical efficacy trials of GHRP-6 have been completed[13].
  • ▪Hunger & injection-site reactions: Marked appetite/hunger is expected; mild redness or soreness at the site can occur, and rotating sites helps.
  • ▪Cortisol / prolactin & unknown long-term profile: A modest rise in cortisol and prolactin can occur; human long-term safety data is limited, so caution and monitoring are advised.
  • ▪Sport restriction: Note that GHRP-6 is a WADA-prohibited substance for athletes.

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14][15].

  • ▪Wash your hands well with soap and water.
  • ▪Wipe the vial stopper with an alcohol swab and let it air-dry.
  • ▪Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[15].
  • ▪Draw the intended dose, then check for air bubbles and push any out.
  • ▪Pinch a skinfold at the chosen site between thumb and forefinger.
  • ▪Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
  • ▪Skip aspiration for subcutaneous shots — it isn’t needed[14].
  • ▪Press the plunger slowly and steadily until it’s fully down.
  • ▪Wait 5–10 seconds, then pull the needle straight out to prevent leakage.
  • ▪Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
  • ▪Return the reconstituted vial to the fridge right away.
  • ▪Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
  • ▪Watch the site for excess redness, swelling, or signs of infection.

References

Reference-derived details for GHRP-6 Acetate 10mg.

  • GHRP-6 (10mg Vial) Dosage Protocol Open source
  • 1 Endocrinology (PubMed) Pharmacology of GHRP-6 as a growth-hormone-releasing peptide acting at the ghrelin/GHS-R1a receptor. View Source ↗ Open source
  • 2 Journal of Clinical Endocrinology & Metabolism (PubMed) GHRP-6 stimulates growth-hormone secretion via the ghrelin receptor in human subjects. View Source ↗ Open source
  • 3 WADA Scientific Research Appetite stimulation and dose-response of GH-releasing peptides such as GHRP-6. View Source ↗ Open source
  • 4 Growth Hormone & IGF Research (PubMed) GH-response plateau and dosing characteristics of GH secretagogues including GHRP-6. View Source ↗ Open source
  • 5 Journal of Endocrinology (PubMed) GHRP-6 induces growth-hormone release in preclinical models via the GHS receptor. View Source ↗ Open source
  • 6 Peptides (PubMed) Structure and GH-releasing activity of GHRP-6 and related ghrelin-receptor agonists. View Source ↗ Open source
  • 7 Peptide Storage Guide Best practices for storing lyophilized peptides (temperature, humidity and light protection). View Source ↗ Open source
  • 8 Bacteriostatic Water Guidance Bacteriostatic water for injection: multi-dose vial stability and handling. View Source ↗ Open source
  • 9 NCBI Bookshelf Best practices for subcutaneous injection: aseptic technique and site rotation. View Source ↗ Open source
  • 10 WADA Prohibited List Classification of GHRP-6 and GH secretagogues as prohibited substances in competitive sport. View Source ↗ Open source
  • 11 Clinical Endocrinology (PubMed) GHRP-6 effects on cortisol, prolactin and appetite alongside the growth-hormone pulse. View Source ↗ Open source
  • 12 European Journal of Endocrinology (PubMed) Dose-response of GHRP-6 showing the growth-hormone plateau near ~100 mcg per dose. View Source ↗ Open source
  • 13 ClinicalTrials.gov Trial registry search for GHRP-6; no completed large-scale human efficacy trials for muscle, recovery or anti-aging. View Source ↗ Open source
  • 14 Centers for Disease Control and Prevention (CDC) Subcutaneous injection technique: angle, site and no-aspiration guidance. View Source ↗ Open source
  • 15 Subcutaneous Injection Technique (Patient Education) How to administer a subcutaneous injection: clinical technique guidelines. View Source ↗ Open source
  • 16 Prime Lab Peptides Prime Lab Peptides — research-peptide purity specifications and certificates of analysis. View Source ↗ Open source